GB Sciences Prepares to Launch New Products in Louisiana with Educational Seminars for Doctors and Pharmacists

A federal court has ordered the Drug Enforcement Administration (DEA) to explain why it has not responded to nearly two dozen applications to grow cannabis for research purposes after Dr. Sue Sisley and the Scottsdale Research Institute (SRI) filed a lawsuit against the Justice Department and the DEA in June.

SRI, a Phoenix-based clinical trial company, applied for a DEA manufacturing license in 2016 to grow its own cannabis for an ongoing study on medical marijuana as a treatment for veterans suffering from post-traumatic stress disorder (PTSD).

The quality of cannabis supplied by the University of Mississippi—the only organization licensed to grow cannabis for medical research in the U.S.—was an ongoing issue during SRI’s PTSD study, the Phoenix New Times reported last year.

The DEA announced in August 2016 that it would start accepting new cultivation license applications and received 25

... read more at:


Leave a Reply